Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      WITHDRAWN
      PET and MRI Imaging With Scopolamine at the Muscarinic M1 Receptor
      Description

      The purpose of this study is to assess the target occupancy (TO) of scopolamine at M1 Muscarinic Receptors in the brain after single I.V. doses of scopolamine, in healthy control subjects, using the radiotracer \[11C\]EMO (also known as \[11C\]LSN3172176).

      Conditions
      Muscarinic Receptor Occupancy
      Talk to us